logo
Select company
Select metric
1034.75%Interest Expense Margin
VS
Market
1
Sector
1
Industry
2
History
-
$ 5.35Close
$ 4.18 - $ 7.23 52-Week Range
Ticker Information

Ticker

ABEO

Company Name

ABEONA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ABEONA THERAPEUTICS INC - Interest Expense Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABEO - Int. Exp. % Historical data
DateInterest ExpenseInterest Expense MarginRevenues
6/30/2025$ 4.14M1034.75%$ 400K
3/31/2025$ 4.25M0%$ 0
12/31/2024$ 4.21M0%$ 0
9/30/2024$ 3.23M0%$ 0
6/30/2024$ 2.24M0%$ 0
3/31/2024$ 1.27M36.26%$ 3.5M
12/31/2023$ 418K11.94%$ 3.5M
9/30/2023$ 487K13.65%$ 3.57M
6/30/2023$ 539K15.11%$ 3.57M
3/31/2023$ 753K70.51%$ 1.07M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ABEONA THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 44.67%.
  • Over the past 5 years, ABEONA THERAPEUTICS INC's average Int. Exp. % has been 114.62%.
  • The median Int. Exp. % for ABEONA THERAPEUTICS INC during this period was 47.01%
  • ABEONA THERAPEUTICS INC reached its highest Int. Exp. % over the past 5 years at 1034.75%.
  • The lowest Int. Exp. % recorded by ABEONA THERAPEUTICS INC in the same timeframe 11.94%

ABEONA THERAPEUTICS INC's Int. Exp. % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Exp. % Benchmarks
CompanyInt. Exp. %
MREO : MEREO BIOPHARMA GROUP PLC 186.4%CRDF : CARDIFF ONCOLOGY INC 0%COYA : COYA THERAPEUTICS INC 0%AVTX : AVALO THERAPEUTICS INC -494.33%ABVC : ABVC BIOPHARMA INC 59.7%IBIO : IBIO INC 53%MBX : MBX BIOSCIENCES INC -ATXS : ASTRIA THERAPEUTICS INC -LRMR : LARIMAR THERAPEUTICS INC -PULM : PULMATRIX INC 0%

Definition of Interest Expense Margin

[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
Int. Exp. / Revenues
(=) Int. Exp. %
Int. Exp. % for ABEONA THERAPEUTICS INC is calculated as follows: Int. Exp. [ $ 3.13M ] / Revenues [ $ 7M ]
(=) Int. Exp. % [ 44.67% ]

ABEO - Interest Expense Margin, Last 5 years

11.94%

Minimum

Dec 31, 2023

1034.75%

Maximum

Jun 30, 2025

114.62%

Average

47.01%

Median

Int. Exp. % Benchmark Analysis

The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
filtered constituents3.15K
min-4.94%
max8.48%
average1.62%
median0.79%
std2.19%